Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Chromatintech Beijing Co. Ltd. holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently includes 2 pending office actions. These actions are distributed across 2 distinct examiners and 2 distinct art units, showing a lack of concentration in the current prosecution phase.
SMITH, JENNIFER JOY is the busiest examiner for this portfolio, responsible for 1 pending office action. This indicates that each of the 2 pending office actions is assigned to a different examiner. Furthermore, the presence of 2 distinct art units suggests that the pending matters cover different technical sub-specialties within the Biotechnology & Pharmaceuticals field.
For a practitioner, this distribution requires managing separate examiner relationships. Since the busiest examiner pending count is 1, no single examiner has a dominant influence over the portfolio's active matters. The strategy must be tailored to address the specific requirements of both distinct art units involved in the review of these 2 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SMITH, JENNIFER JOY | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17796446 | METHOD FOR GENERATING AN ENHANCED HI-C MATRIX, NON-TRANSITORY COMPUTER READABLE MEDIUM STORING A PROGRAM FOR GENERATING AN ENHANCED HI-C MATRIX, METHOD FOR IDENTIFYING A STRUCTURAL CHROMATIN ABERRATION IN AN ENHANCED HI-C MATRIX, AND METHODS FOR DIAGNOSING AND TREATING A MEDICAL CONDITION OR DISEASE | SMITH, JENNIFER JOY | — |
| Art Unit | Apps |
|---|---|
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17796446 | METHOD FOR GENERATING AN ENHANCED HI-C MATRIX, NON-TRANSITORY COMPUTER READABLE MEDIUM STORING A PROGRAM FOR GENERATING AN ENHANCED HI-C MATRIX, METHOD FOR IDENTIFYING A STRUCTURAL CHROMATIN ABERRATION IN AN ENHANCED HI-C MATRIX, AND METHODS FOR DIAGNOSING AND TREATING A MEDICAL CONDITION OR DISEASE | SMITH, JENNIFER JOY | 1685 | §101§103 | Final Rejection | — | Pending | Jul 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChromatintech Beijing Co. Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Jennifer Joy Smith has the most, with 1 of Chromatintech Beijing Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.